3Taieb A. Intrinsic and extrimic pathomechanisam in vitiligo. Pigment Cell Res, 2003,13(Suppl 8):41.
4Kamat BR, Carney J, Amdt KA, et al. Cutaneous tissue repair following CO2 laser irradiation. J Incest Dermatol, 1986, 87:268.
5Kim SM, Lee HS, Hann SK .The efficacy of low-dose oral corti costeroids in the treatment of vitiligo patients [J]. Int J Dermatol. 1999, 38(7):546-550.
6Zachariae H. Autotransplantation in vitiligo: treatment with epithe lial sheet grafting orq cultured melanocytes [J]. J Am Acad Dermatol, 1994,30(6):1044.
7Falabella R. What's new in the treatment of vitiligo [J]. J Eur Acad Dermatol Venereol, 2001,15(4):287-289.
8Halder RM, Young CM. New and emerging therapies for vitiligo. [J] Dermatol Clin, 2000,18(1):79-89.
3Gupta S, Kumar B. Epidermal grafting in vitiligo: influence of age, site of lesion, and type of disease on outcome. J Am Acad Dermatol, 2003, 49(1 ): 99-104.
5Czajkowski R, Placek W, Drewa T, et al. Autologous cultured melanocytes in vitiligo treatment. Dermatol Surg, 2007, 33 (9): 1027-1036.
6Le Poole IC, Wankowicz-Kalinska A, van den Wijngaard RM, et al. Autoimmune aspects of depigmentation in vitiligo [J]. J In- vestig Dermatol Syrup Proe, 2004, 9(1): 68-72.
7Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoim- mune pathogenesis of vitiligo[J]. Pigment Cell Res, 2003, 16(2): 90-100.
8Schallreuter KU, Moore J, Wood JM, et al. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epi- dermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase[J]. J Investig Dennatol Symp Proc, 1999, 4(1): 91-96.
9Zhang XY, He YL, Dong J, et al. Clinical efficacy of a 308 nm excimer laser in the treatment of vitiligo[J]. Photodermatol Pho- to-immunol Photomed, 2010, 26(3): 138-142.
10Yang YS, Cho HR, Ryou JH, et al. Clinical study of repigmen- tation patterns with either narrow-band ultraviolet B (NB-UVB) or 308 nm excimer laser treatment in Korean vitiligo patients [J]. Int J Dermatol, 2010, 49(3): 317-323.
